Neufeld, Austria

Laszlo Czollner


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Neufeld, AT (2000 - 2006)
  • Ebenfurth, AT (2007 - 2013)

Company Filing History:


Years Active: 2000-2013

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Laszlo Czollner

Introduction

Laszlo Czollner is a notable inventor based in Neufeld, Austria. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on developing novel compounds and methods that have the potential to impact medical treatments.

Latest Patents

Czollner's latest patents include innovative compounds and methods. One of his notable inventions is the N-hydroxy C29-amide derivatives of oleandrane. This invention encompasses novel triterpene compounds that are suitable for the prevention and/or treatment of diseases mediated by 11 β-HSD. The compounds are designed for use in preparing medicaments with these properties. Another significant patent is the method for producing salts of tolperisone. This invention relates to a method for producing an addition salt of tolperisone with a pharmaceutically acceptable acid. The process involves reacting 4-methylpropiophenone with piperidine hydrochloride and 1,2-dioxolane in the presence of an acid catalyst.

Career Highlights

Throughout his career, Czollner has worked with various companies, including Sanochemia Pharmazeutika AG and Sanochemia Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Czollner has collaborated with notable professionals in his field, including Ulrich Jordis and Johannes Frohlich. These collaborations have likely enhanced his research and development efforts.

Conclusion

Laszlo Czollner's contributions to the field of pharmaceuticals through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments and methodologies in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…